Trekturnaدواء جديد لعلاج الضغط
Novartis has received a positive opinion recommending European Union approval of Rasilez® as the first new type of high blood pressure treatment in more than a decade
Rasilez is the first in a new class of drugs called direct renin inhibitors. It acts by directly inhibiting renin, an enzyme that triggers a process leading to high blood pressureThe medication received its first approval in March 2007 from the US Food and Drug Administration under the trade name Tekturna
رد مع اقتباس
